In other AbbVie news, SVP Azita Saleki-Gerhardt sold 8,300 shares of the stock in a transaction that occurred on Monday, September 11th. Its position was valued at $687,591,000 an increase of 22.0% as of the end of the quarter. 38,300 AbbVie Inc (NYSE:ABBV) shares with value of $2.50 million were sold by CHASE WILLIAM J. The stock ended last trade at $95.12 a share and the price is up more than 51.90% so far this year.
Traders are a little more bullish on shares of Abbvie Inc. It has underperformed by 23.07% the S&P500. BidaskClub upgraded shares of AbbVie from a "buy" rating to a "strong-buy" rating in a report on Saturday. It also upped Flex Ltd (NASDAQ:FLEX) stake by 6.68 million shares and now owns 38.16 million shares. Ameriprise Financial Inc. now owns 10,364,784 shares of the company's stock worth $641,739,000 after buying an additional 3,562,980 shares in the last quarter.
Here are some institutional investors who have increased or decreased their stake in (ABBV). The stock increased 0.83% or $0.33 during the last trading session, reaching $40.31. AbbVie Inc (NYSE:ABBV) has risen 10.63% since November 14, 2016 and is uptrending. It has underperformed by 24.14% the S&P500. Therefore 57% are positive. $56.40's average target is 39.92% above currents $40.31 stock price. The stock has "Buy" rating by Needham on Wednesday, May 11. The firm earned "Hold" rating on Friday, August 5 by Vertical Research. This gauge is crucial in determining whether investors are moved toward the direction of buying more of the stock, or else doing the contradictory side and selling more of the stock. Barclays PLC restated a "hold" rating and issued a $68.00 target price on shares of AbbVie in a report on Thursday, September 28th. The stock has "Hold" rating by BMO Capital Markets on Thursday, April 13. Jefferies upgraded it to "Buy" rating and $55 target in Monday, December 7 report. The rating was maintained by Deutsche Bank on Tuesday, July 18 with "Buy".
Since May 15, 2017, it had 0 insider purchases, and 1 sale for $137,623 activity. Jana Partners Llc acquired 112,156 shares as Dermira Inc (DERM)'s stock declined 17.23%. About 433,090 shares traded.
More important recent Mobileiron Inc (NASDAQ:MOBL) news were published by: Businesswire.com which released: "SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of MobileIron, Inc." on October 18, 2017, also Prnewswire.com published article titled: "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...", Prnewswire.com published: "SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ..." on October 19, 2017. The stock saw a fall in short interest between October 13, 2017 and October 31, 2017 of -11.06%. Its up 6.58, from 1.06 in 2017Q1. Cwm Ltd Llc reported 0.28% stake. First Natl Bank Of Omaha owns 0.08% invested in AbbVie Inc (NYSE:ABBV) for 18,388 shares. Overbrook Mgmt accumulated 44,667 shares. City Holding invested 0.02% in Ball Corporation (NYSE:BLL). Mason Street Limited Liability reported 48,592 shares. Td Asset Management Inc reduced its investment by shedding 4,842 shares a decrease of 0.7% in the quarter. Stock's free cash flow yield, which represents the amount of cash available to investors before dividends, expressed as a percentage of the stock price, is 0.84. 5,598 were reported by Signature Mngmt Inc. "Buys DowDuPont Inc, Red Hat Inc, AbbVie ..." on November 02, 2017. Synovus Corp stated it has 0.24% of its portfolio in AbbVie Inc (NYSE:ABBV). Its down 0.50, from 1.89 in 2017Q1. It improved, as 55 investors sold ABBV shares while 581 reduced holdings. Pennsylvania Tru holds 0.88% or 244,995 shares in its portfolio. Tekla Capital Ltd Liability Com owns 386,900 shares. Sumitomo Mitsui holds 4.57M shares or 0.49% of its portfolio. Checchi Cap Advisers Lc, California-based fund reported 16,219 shares. Centurylink Invest Mgmt Company invested 0.27% of its portfolio in AbbVie Inc (NYSE:ABBV). Private Ocean Limited Company holds 1,400 shares or 0.07% of its portfolio. Clough Capital Prtnrs LP holds 0.37% in Dermira Inc (NASDAQ:DERM) or 181,785 shares. 26,774 are held by National Asset Management. Strategic Llc holds 1.54% or 46,529 shares in its portfolio. Sei Invs owns 104,691 shares or 0% of their U.S. portfolio. 1,530 were reported by Point72 Asia (Hong Kong) Ltd. They expect $0.36 earnings per share, up 9.09% or $0.03 from last year's $0.33 per share. Employees Retirement System Of Texas reported 0.2% in AbbVie Inc (NYSE:ABBV). The company reported $1.41 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.39 by $0.02. ABBV's profit will be $2.28B for 16.31 P/E if the $1.43 EPS becomes a reality.
Analysts await AbbVie Inc (NYSE:ABBV) to report earnings on January, 26. 71,235 shares were sold by GONZALEZ RICHARD A, worth $4.67M. The value of the position overall is up by 21.5%. Therefore 52% are positive. The business's revenue was up 8.8% on a year-over-year basis. equities research analysts anticipate that AbbVie Inc. will post 5.55 EPS for the current year. Raymond James initiated AbbVie Inc (NYSE:ABBV) on Friday, September 2 with "Outperform" rating. The stock has "Hold" rating by Credit Suisse on Thursday, July 20. The company has grown sales at a 2.00% annual rate over the past five years, putting it in the low growth category. The company was maintained on Friday, July 28 by Cowen & Co. As per Sunday, October 29, the company rating was maintained by SunTrust. Cantor Fitzgerald has "Buy" rating and $4500 target. The company was maintained on Friday, August 18 by Jefferies.